| ABL1 |
P00519
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
Kinase
|
1.00 |
0.432 |
0.923 |
| ASXL1 |
Q8IXJ9
|
ASXL transcriptional regulator 1
|
|
1.3E-14 |
0.482 |
0.808 |
| ATM |
Q13315
|
ATM serine/threonine kinase
|
Kinase
|
5.6E-47 |
0.374 |
0.885 |
| BCR |
P11274
|
BCR activator of RhoGEF and GTPase
|
Enzyme modulator
|
0.99 |
0.431 |
0.885 |
| BRCA1 |
P38398
|
BRCA1 DNA repair associated
|
Enzyme
|
9.2E-29 |
0.367 |
0.923 |
| BRCA2 |
P51587
|
BRCA2 DNA repair associated
|
Nucleic acid binding
|
2.4E-25 |
0.379 |
0.846 |
| BRIP1 |
Q9BX63
|
BRCA1 interacting protein C-terminal helicase 1
|
Enzyme
|
6.2E-17 |
0.507 |
0.731 |
| CD34 |
P28906
|
CD34 molecule
|
|
5.0E-06 |
0.368 |
0.808 |
| CSF2 |
P04141
|
colony stimulating factor 2
|
Signaling
|
0.83 |
0.330 |
0.962 |
| CSF3 |
P09919
|
colony stimulating factor 3
|
|
0.38 |
0.377 |
0.885 |
| CTC1 |
Q2NKJ3
|
CST telomere replication complex component 1
|
|
1.6E-11 |
0.601 |
0.538 |
| CUX1 |
P39880 Q13948
|
cut like homeobox 1
|
Transcription factor
|
1.00 |
0.465 |
0.846 |
| DERL1 |
Q9BUN8
|
derlin 1
|
Receptor
|
2.1E-04 |
0.576 |
0.654 |
| EPO |
P01588
|
erythropoietin
|
|
1.1E-02 |
0.381 |
0.885 |
| FANCA |
O15360
|
FA complementation group A
|
|
1.6E-68 |
0.505 |
0.731 |
| FANCB |
Q8NB91
|
FA complementation group B
|
|
1.00 |
0.468 |
0.769 |
| FANCC |
Q00597
|
FA complementation group C
|
|
2.8E-13 |
0.507 |
0.808 |
| FANCD2 |
Q9BXW9
|
FA complementation group D2
|
|
1.1E-30 |
0.479 |
0.885 |
| FANCE |
Q9HB96
|
FA complementation group E
|
|
1.5E-06 |
0.553 |
0.808 |
| FANCF |
Q9NPI8
|
FA complementation group F
|
|
0.46 |
0.535 |
0.731 |
| FANCG |
O15287
|
FA complementation group G
|
|
2.5E-14 |
0.556 |
0.769 |
| FANCI |
Q9NVI1
|
FA complementation group I
|
|
8.9E-37 |
0.543 |
0.731 |
| FANCL |
Q9NW38
|
FA complementation group L
|
Enzyme
|
5.9E-23 |
0.551 |
0.731 |
| FANCM |
Q8IYD8
|
FA complementation group M
|
Enzyme
|
2.4E-15 |
0.543 |
0.731 |
| FLT1 |
P17948
|
fms related receptor tyrosine kinase 1
|
Kinase
|
1.00 |
0.419 |
0.846 |